Moleculin Biotech, Inc. (MBRX) Q1 2025 Earnings Call Transcript

  • Moleculin Biotech, Inc. (NASDAQ:MBRX ) Q1 2025 Earnings Conference Call May 14, 2025 8:30 AM ET Company Participants Jenene Thomas - IR, JTC Team, LLC Walter Klemp - Founder, President, CEO and Chairman Paul Waymack - Senior Chief Medical Officer Jonathan Foster - Executive VP & Chief Financial Officer Conference Call Participants Jonathan Aschoff - ROTH Capital Partners Jason McCarthy - Maxim Group Operator Good morning. Welcome to the Moleculin Biotech First Quarter 2025 Update Conference Call and Webcast.